ERAS

Erasca, Inc.

CIK 0001761918 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations

$17.63

↑ 0.55 (3.22%)

as of Aug 21, 2026

End-of-day close, not real-time intraday

Live price (Google Finance) ↗

Overall read: NeutralOverall score · based on 4/4 lenses

FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals

Key stats

Market Cap

$6.17B

P/E Ratio

-21.47

EPS

-0.44

Dividend Yield

Not covered

52W Position

71%

Beta

1.09

Valuation multiples

Fwd P/E

Not covered

PEG

Not covered

P/B

17.04

P/S

Not covered

EV/Revenue

Not covered

ROE

-79.4%

Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 71%

$1.33$24.28

Latest Financials

2025-12-31 FY

Revenue

–

Net Income

-$124.55M

Total Assets

$396.15M

Free Cash Flow

-$95.58M

ERAS

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

ERAS

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news